, Tracking Stock Market Picks
Enter Symbol:

up 894.91 %

PHARMASSET INC. (VRUS) rated Outperform with price target $35 by MP Advisors

Posted on: Tuesday,  Sep 14, 2010  11:25 AM ET by MP Advisors

MP Advisors rated Outperform PHARMASSET INC. (NASDAQ: VRUS) on 09/14/2010, when the stock price was $13.77. Since
then, PHARMASSET INC. has gained 894.91% as of 01/17/2012's recent price of $136.95.
If you would have followed this MP Advisors's recommendation on VRUS, you would have gained 894.91% of your investment in 490 days.

Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of drugs to treat viral infections. It focuses on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).

MP Advisors helped investors navigate the dynamic BioPharma industry for decades. Our flagship BioPharmaceutical Outlook™ maps the highs and lows of the year, assessing the critical success factors that can shape the industry's future.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/14/2010 11:25 AM Buy
13.77 17.50
as of 12/31/2010
1 Week up  10.46 %
1 Month up  12.30 %
3 Months up  65.25 %
1 YTD up  76.71 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy